Morgan Stanley raised its price target on Rivian to $17 from $13. Meanwhile, Jefferies upgraded UnitedHealth to buy from hold. Check out the latest calls and chatter below. All times ET. 6:30 a.m.: UBS initiates Sweetgreen with a buy rating UBS sees a healthy outlook ahead for Sweetgreen . The bank initiated shares of the fast-casual salad chain with a buy rating and set a $31 price target. This implies nearly 16% upside for the stock.
mountain 2024-06-25 since June 25 "VW's cash reduces near term vol in the stock but it doesn't change our view that Rivian may have a better future as a Tier 1 supplier/SDV 'tech partner' than as a stand-alone maker of EVs," wrote Jonas, who kept his overweight rating on shares.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: